Search Results

You are looking at 1 - 2 of 2 items for :

  • "anti-CD38" x
  • All content x
Clear All
Authors: Apor Hardi, András Kozma, Andrea Ceglédi, Ágnes Tomán, András Bors, Hajnalka Andrikovics, and Gábor Mikala

, Richter J, Vij R, Cole C, Zonder J, et al. A dose-finding Phase 2 study of single agent isatuximab (anti-CD38 mAb) in relapsed/refractory multiple myeloma. Leukemia 2020; 34: 3298–3309. 10.1038/s41375

Restricted access

and Blood-Compatibility Testing. The New England Journal of Medicine 2016; 375: 2497–2498. 16 Myeloma multiplexes betegek anti-CD38 monoklonális antitest

Restricted access